Showing results (1721-1730 of 2,090) with videos related to

Sort By:
Pageof 209
Oncotarget|March 10, 2016
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancerJhajaira M Araujo, Alexandra Prado, Nadezhda K Cardenas, et al.
Academic Radiology|January 14, 2025
Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI: A Retrospective Monocentric StudyOmer Tarik Esengur, Enis C Yilmaz, Benjamin D Simon, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trialCarolina Porras, Byron Romero, Troy Kemp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
Predicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate CancerTim E Phelps, Stephanie A Harmon, Esther Mena, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 6, 2016
Physalin F, a seco-steroid from Physalis angulata L., has immunosuppressive activity in peripheral blood mononuclear cells from patients with HTLV1-associated myelopathyLorena A Pinto, Cássio S Meira, Cristiane F Villarreal, et al.
Frontiers in Oncology|January 24, 2014
Comparison of antibody responses to human papillomavirus vaccination as measured by three assaysHilary A Robbins, Troy J Kemp, Carolina Porras, et al.
JNCI Cancer Spectrum|December 18, 2020
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its PrecursorJonathan N Hofmann, Ola Landgren, Rebecca Landy, et al.
Pageof 209